SLC7A11 and neurodegenerative disease: Inhibition of GPX4 or SLC7A11 can result in ferroptosis.[10,13,14] Due to its close association with neurodegenerative diseases, cancer, and diabetes, ferroptosis has received considerable attention as a potential therapeutic target.[15–18]